Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

1.2K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.2K
Tumor Immunotherapy01:27

Tumor Immunotherapy

600
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
600
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

1.1K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.1K
The Tumor Microenvironment02:17

The Tumor Microenvironment

6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

1.4K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Distinct clinical, molecular, and treatment response profiles in primary and secondary myelofibrosis: a single-center retrospective study.

Hematology (Amsterdam, Netherlands)·2026
Same author

A survival prognostic model for high-risk myelodysplastic syndrome patients treated with decitabine.

Hematology (Amsterdam, Netherlands)·2026
Same author

Rapamycin and Cyclosporin A Alleviate Bone Marrow Adiposity in Murine Model of Aplastic Anemia.

Clinical laboratory·2026
Same author

Somatic Mutations and Mutation Burden Predict Treatment Response and Survival in Adult Acquired Pure Red Cell Aplasia.

American journal of hematology·2026
Same author

Immune-Mediated Multilineage Cytopenias in Thymoma: A Retrospective Case Series.

Thoracic cancer·2026
Same author

The Immunoregulatory and Hematopoietic Effects of Momelotinib in a Murine Bone Marrow Failure Model.

Journal of clinical laboratory analysis·2026

Related Experiment Video

Updated: Aug 5, 2025

Adenoviral Transduction of Naive CD4 T Cells to Study Treg Differentiation
15:33

Adenoviral Transduction of Naive CD4 T Cells to Study Treg Differentiation

Published on: August 13, 2013

16.0K

TOX regulates T lymphocytes differentiation and its function in tumor.

Haiyue Niu1, Huaquan Wang1

  • 1Department of Hematology, General Hospital, Tianjin Medical University, Tianjin, China.

Frontiers in Immunology
|March 27, 2023
PubMed
Summary

Thymocyte selection-associated high mobility group box protein (TOX) exhibits varied expression during T lymphocyte development. Understanding TOX heterogeneity offers insights into T cell function and potential therapeutic targets for various diseases.

Keywords:
CD4CD8T-cell exhaustionTOXtumor

More Related Videos

Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice
07:17

Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice

Published on: June 22, 2016

9.9K
Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis
07:45

Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis

Published on: January 26, 2024

2.0K

Related Experiment Videos

Last Updated: Aug 5, 2025

Adenoviral Transduction of Naive CD4 T Cells to Study Treg Differentiation
15:33

Adenoviral Transduction of Naive CD4 T Cells to Study Treg Differentiation

Published on: August 13, 2013

16.0K
Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice
07:17

Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice

Published on: June 22, 2016

9.9K
Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis
07:45

Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis

Published on: January 26, 2024

2.0K

Area of Science:

  • Immunology
  • Molecular Biology
  • Genetics

Background:

  • Thymocyte selection-associated high mobility group box protein (TOX) plays a role in T lymphocyte development.
  • Recent advancements, including single-cell sequencing, have highlighted the heterogeneity of T lymphocytes and TOX expression.
  • Exploring this heterogeneity is crucial for understanding T cell biology.

Purpose of the Study:

  • To investigate the heterogeneity of TOX expression in T lymphocytes.
  • To elucidate the functional implications of TOX heterogeneity in T cell activation and exhaustion.
  • To explore the potential of TOX as a therapeutic target and prognostic marker.

Main Methods:

  • Single-cell sequencing technologies
  • Analysis of TOX expression patterns across T lymphocyte developmental stages
  • Functional assays to assess T cell activation and exhaustion

Main Results:

  • TOX exhibits differential expression patterns throughout T lymphocyte development, indicating significant heterogeneity.
  • TOX regulation is implicated in both T cell exhaustion and activation.
  • Heterogeneity in TOX expression correlates with distinct T cell functional states.

Conclusions:

  • TOX heterogeneity is a key feature of T lymphocyte development and function.
  • Targeting TOX presents potential therapeutic strategies for autoimmune diseases, chronic infections, and tumors.
  • TOX serves as a critical factor for predicting patient response to therapies and overall survival in cancer.